Una nueva herramienta de predicción de riesgos, desarrollada por anestesiólogos de Montefiore Health System y Albert Einstein College Medicine, podría reducir los efectos adversos BRONX, Nueva York, 23 de agosto de 2024 /PRNewswire-HISPANIC PR WIRE/– Una nueva herramienta informática de…

SHANGHAI, Aug. 23, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced China’s National Medical Products Administration has approved Dupert®(fulzerasib, GFH925/IBI351)for the treatment…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.